The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Will The Market Value Of The Contraceptive Drugs And Devices Market Change Between 2026 And 2030?
The contraceptive drugs and devices market has experienced robust growth in recent years. It is anticipated to expand from $26.98 billion in 2025 to $28.9 billion in 2026, progressing at a compound annual growth rate (CAGR) of 7.1%. This historical expansion can be linked to government-led family planning initiatives, enhanced awareness of reproductive health, increasing urbanization and education levels, greater accessibility of oral contraceptives, and public health campaigns focused on birth control.
The market for contraceptive drugs and devices is projected to experience substantial expansion in the coming years. Its valuation is anticipated to reach $38.08 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.1%. This forecasted expansion is primarily driven by factors such as enhanced digital health integration, increasing consumer preference for non-invasive contraception, the broadening scope of telehealth for prescriptions, heightened research into male contraception, and supportive government policies related to reproductive health. Key developments expected during this period involve a greater uptake of long-acting reversible contraceptives, more widespread application of hormonal combination therapies, a growing emphasis on contraceptive options for women, the wider availability of over-the-counter contraceptive items, and increasing comfort with digital platforms for contraception.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24197&type=smp
What Key Growth Drivers Are Influencing The Contraceptive Drugs And Devices Market?
An increasing number of government initiatives concerning reproductive health is anticipated to drive the growth of the contraceptive drugs and devices market moving forward. These governmental efforts promote reproductive well-being through heightened awareness, financial provision, and improved access to essential services. The rise in government initiatives related to reproductive health is due to a growing recognition of the importance of addressing issues such as maternal health, family planning, and access to fundamental healthcare services, which are critical for overall societal welfare and development. Government programs for contraceptive drugs and devices aim to enhance the availability of affordable and effective family planning methods, ensuring individuals can make informed choices about their reproductive health. For instance, in November 2024, according to the Australian Government Department of Foreign Affairs and Trade, an Australia-based government agency, Australia is set to allocate $56.8 million to a new project focused on advancing sexual and reproductive health and rights in Southeast Asia. Consequently, the escalating number of government initiatives regarding reproductive health is fueling the expansion of the contraceptive drugs and devices market.
Which Segment Divisions Form The Structure Of The Contraceptive Drugs And Devices Market?
The contraceptive drugs and devices market covered in this report is segmented –
1) By Product: Contraceptive Drugs, Contraceptive Devices
2) By Technology: Traditional Methods, Wearable Devices, Long-Acting Reversible Contraceptives (LARCs)
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channels And Non-Governmental Organizations, Other Distribution Channels
4) By End User: Male, Female
Subsegments:
1) By Contraceptive Drugs: Oral Contraceptive Pills, Injectable Contraceptives, Contraceptive Patches, Vaginal Rings, Emergency Contraceptive Pills, Hormonal Implants
2) By Contraceptive Devices: Male Condoms, Female Condoms, Intrauterine Devices (IUDs), Diaphragms And Cervical Caps, Contraceptive Sponges, Sterilization Devices
What Trends Are Influencing The Contraceptive Drugs And Devices Market?
Leading companies in the contraceptive drugs and devices market are developing innovative products, such as contraceptive vaginal rings, to enhance user convenience and expand long-acting contraceptive options. A contraceptive vaginal ring is a flexible, hormone-releasing device placed into the vagina to prevent pregnancy by inhibiting ovulation. For instance, in October 2023, Xiromed LLC, a US-based pharmaceutical company, introduced EnilloRing, a soft, flexible, contraceptive vaginal ring designed for vaginal insertion, where it steadily releases a combination of etonogestrel (a progestin) and ethinyl estradiol (an estrogen) over three weeks to prevent ovulation. As a bioequivalent generic to NuvaRing, it provides women with a convenient, discreet, and cost-effective monthly birth control option that removes the need for daily dosing while maintaining the same safety, efficacy, and tolerability profile as the branded version.
Which Companies Are Influencing The Contraceptive Drugs And Devices Market?
Major companies operating in the contraceptive drugs and devices market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co Inc., Bayer AG, Viatris Inc., Teva Pharmaceuticals Ltd, Lupin Limited, CooperSurgical Inc., Mithra Pharmaceuticals, DKT International, Fuji Latex Co Ltd, Agile Therapeutics Inc., Cupid Limited, Veru Inc., Eskag Pharma Pvt. Ltd., Biosante Pharmaceuticals Inc., HLL Lifecare Limited, Afaxys Inc., The Female Health Company (FC2), Mayer Laboratories Inc., Daré Bioscience Inc.
Access The Complete Contraceptive Drugs And Devices Market Report:
Which Region Contributes The Most To The Contraceptive Drugs And Devices Market?
North America was the largest region in the contraceptive drugs and devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptive drugs and devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Contraceptive Drugs And Devices Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=24197&type=smp
Browse Through More Reports Similar to the Global Contraceptive Drugs And Devices Market 2026, By The Business Research Company
Contraceptive Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/contraceptive-devices-global-market-report
Contraceptives Market Report 2026
https://www.thebusinessresearchcompany.com/report/contraceptives-global-market-report
Oral Contraceptive Pills Market Report 2026
https://www.thebusinessresearchcompany.com/report/oral-contraceptive-pills-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model